ID
14031
Description
Azacytidine (Vidaza®) Versus Fludarabine and Cytarabine (Fluga Scheme) in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT02319135
Link
https://clinicaltrials.gov/show/NCT02319135
Keywords
Versions (1)
- 3/22/16 3/22/16 -
Uploaded on
March 22, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Acute Myeloid Leukemia NCT02319135
Eligibility Acute Myeloid Leukemia NCT02319135
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Acute Promyelocytic Leukemia
Data type
boolean
Alias
- UMLS CUI [1]
- C0023487
Description
aml secondary to myelodysplastic syndrome
Data type
boolean
Alias
- UMLS CUI [1]
- C0280449
Description
treatment with hydroxyurea prior to randomization is allowed.
Data type
boolean
Alias
- UMLS CUI [1]
- C3665472
Description
serum creatinine
Data type
boolean
Alias
- UMLS CUI [1]
- C0600061
Description
bilirubin, alkaline phosphatase
Data type
boolean
Alias
- UMLS CUI [1]
- C0005437
- UMLS CUI [2]
- C0002059
Description
Life-threatening disease
Data type
boolean
Alias
- UMLS CUI [1]
- C1517874
Description
concomitant disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0243087
Description
Mental disorders
Data type
boolean
Alias
- UMLS CUI [1]
- C0004936
Description
life expectancy
Data type
boolean
Alias
- UMLS CUI [1]
- C0023671
Description
No informed consent
Data type
boolean
Alias
- UMLS CUI [1]
- C0021430
Similar models
Eligibility Acute Myeloid Leukemia NCT02319135
- StudyEvent: Eligibility
C0002059 (UMLS CUI [2])